Verastem, Inc. (VSTM): Price and Financial Metrics
VSTM Price/Volume Stats
| Current price | $5.33 | 52-week high | $14.22 |
| Prev. close | $5.28 | 52-week low | $2.10 |
| Day low | $5.12 | Volume | 701,200 |
| Day high | $5.42 | Avg. volume | 2,011,827 |
| 50-day MA | $4.73 | Dividend yield | N/A |
| 200-day MA | $4.93 | Market Cap | 237.22M |
VSTM Stock Price Chart Interactive Chart >
Verastem, Inc. (VSTM) Company Bio
Verastem, Inc. focuses on discovering and developing drugs for the treatment of cancer. Its programs target the focal adhesion kinase (FAK) and the phosphoinositide 3-kinase (PI3K)/mTOR signaling pathways. The company was founded in 2010 and is based in Needham, Massachusetts.
VSTM Price Returns
| 1-mo | 27.21% |
| 3-mo | 62.50% |
| 6-mo | 79.46% |
| 1-year | -49.86% |
| 3-year | -69.99% |
| 5-year | -77.10% |
| YTD | 3.09% |
| 2024 | -36.49% |
| 2023 | 68.53% |
| 2022 | -80.37% |
| 2021 | -3.76% |
| 2020 | 58.96% |
Continue Researching VSTM
Here are a few links from around the web to help you further your research on Verastem Inc's stock as an investment opportunity:Verastem Inc (VSTM) Stock Price | Nasdaq
Verastem Inc (VSTM) Stock Quote, History and News - Yahoo Finance
Verastem Inc (VSTM) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...